TP53 and esophageal squamous cell carcinoma: Only 16.67% of TP53 mutations in SCCOT [26] (as compared to 27.59% in ESCC) were expected to result in p53 truncation, further suggesting differences in biology of SCCOT and ESCC with respect to p53 function.